After Hours
$
15.36
Change
0.00 0.00%
Volume
Volume 2,836
Mar 23, 2023, 5:05 p.m.
Quotes are delayed by 20 min
Previous close
$ 15.32
$ 15.36
Change
+0.04 +0.26%
Day low
Day high
$15.00
$15.81

52 week low
52 week high
$7.90
$24.42

Market cap
$601.34M
Average volume
38,089
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-5.08
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on HLVX
-
HilleVax started at buy with $34 stock price target at Stifel Nicolaus
- Tomi Kilgore
-
HilleVax started at overweight with $24 stock price target at J.P. Morgan
- Tomi Kilgore
Other News on HLVX
-
- Edgar Online - (EDG = 10Q, 10K)
-
Top 5 4th Quarter Trades of Abingworth LLP
- GuruFocus.com
-
Top 2 4th Quarter Trades of Qiming U.S. Ventures Management, LLC
- GuruFocus.com
-
- Seeking Alpha
-
Abingworth LLP Buys 2, Sells 3 in 3rd Quarter
- GuruFocus.com
-
- Edgar Online - (EDG = 10Q, 10K)
-
Samsara BioCapital, LLC's Top 5 Buys of the 2nd Quarter
- GuruFocus.com
-
StepStone Group LP Buys 3, Sells 2 in 2nd Quarter
- GuruFocus.com
-
- Edgar Online - (EDG = 10Q, 10K)
-
Biotech Public Offerings at 10-Year Low
- GuruFocus.com
-
Norovirus vaccine developer HilleVax stock jumps 23%
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
HilleVax stock jumps 11% following four analyst buy ratings
- Seeking Alpha
-
HilleVax prices IPO at $17 per share, debuts today
- Seeking Alpha
-
Novovirus vaccine developer HilleVax files for $100M IPO
- Seeking Alpha
- Loading more headlines...
Press Releases on HLVX
-
HilleVax to Participate in November Investor Conferences
- GlobeNewswire
-
HilleVax Announces Pricing of Upsized Initial Public Offering
- GlobeNewswire
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com